Notice convening the extraordinary general meeting of Pharma Equity Group A/S [Yahoo! Finance]
Nasdaq, Inc. (NDAQ)
Last nasdaq, inc. earnings: 4/22 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.nasdaq.com
Company Research
Source: Yahoo! Finance
The board of directors hereby convenes an extraordinary general meeting in Pharma Equity Group A/S ("PEG" or the "Company") to be held on: 3 June 2024, at 15:30 CEST at Wihlborg's Canteens Slotsmarken 15 DK-2970 Hørsholm The agenda for the extraordinary general meeting is as follows: Proposal to reduce the Company's share capital Authorization to the chair of the general meeting Item 1 – Proposal to reduce the Company's share capital The board of directors proposes to reduce the Company's share capital by a nominal value of DKK 920,667,494.7 from a nominal value of DKK 1,022,963,883.00 to a nominal value of DKK 102,296,388.3. The capital reduction does not affect the number of outstanding shares or voting rights in the Company, and, consequently, does not affect the individual investor's number of shares or voting rights. The capital reduction will be made by allocation to a specific reserve pursuant to section 188(1)(3) of the Danish Companies Act. The capital
Show less
Read more
Impact Snapshot
Event Time:
NDAQ
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NDAQ alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NDAQ alerts
High impacting Nasdaq, Inc. news events
Weekly update
A roundup of the hottest topics
NDAQ
News
- Delisting of Securities of Better Therapeutics, Inc.; Tritium DCFC Limited; Arcimoto, Inc.; Next.e.GO N.V.; Acutus Medical, Inc.; and NeuBase Therapeutics, Inc. from The Nasdaq Stock MarketGlobeNewswire
- Nasdaq to Enhance Global Market Surveillance Offering with Generative AIGlobeNewswire
- Nasdaq Announces 2024 Annual Meeting of ShareholdersGlobeNewswire
- Nasdaq, Inc. (NASDAQ: NDAQ) had its price target raised by analysts at Argus from $64.00 to $66.00. They now have a "buy" rating on the stock.MarketBeat
- Nasdaq Weighs Sale of Solovis Amid Streamlining Effort [BNN Bloomberg (Canada)]BNN Bloomberg
NDAQ
Earnings
- 4/26/24 - Miss
NDAQ
Sec Filings
- 5/3/24 - Form 4
- 5/3/24 - Form 8-K
- 5/3/24 - Form 424B7
- NDAQ's page on the SEC website